<DOC>
	<DOCNO>NCT00372086</DOCNO>
	<brief_summary>Type 1 Diabetes common life-long disorder onset childhood . Patients need insulin injection , blood sugar monitor several time day , adhere strict diet . Adequate control blood glucose essential prevent long term kidney eye complication result kidney failure blindness . Adolescence time diabetes difficult control , due part high growth hormone level cause insulin resistance ( state body respond strongly insulin ) . This study test whether treatment rosiglitazone ( oral medication use frequently type 2 diabetes ) reduce insulin resistance adolescence improve control type 1 diabetes puberty .</brief_summary>
	<brief_title>Rosiglitazone Insulin T1DM Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>T1DM duration &gt; 1year age 1018years HbA1c &gt; 8 % puberty &gt; Tanner stage 2 breast testis &gt; 4ml know noncompliance hypo unaware</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>